Statin liver safety in neurology patients
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is looking at the safety of statin medications (cholesterol-lowering drugs) on the liver in people hospitalized for neurological conditions like stroke, headache, or dizziness. The goal is to see if these drugs are safe for this group of patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were hospitalized in the neurology department of Yueyang Hospital between June 2020 and February 2023.
- You are between 18 and 85 years old.
- You have a diagnosis of a cerebrovascular condition (like stroke), headache disorder, or dizziness/vertigo.
- You do not have a diagnosis of cancer or a blood disease (like leukemia or lymphoma).
- You have been taking statin medication for at least 7 days, if you take them at all.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
This study tests whether starting a statin soon after a stroke or mini-stroke helps older adults (70+) who are frail. You will be randomly assigned to receive a statin or a placebo to see if it reduces the chance of another stroke.
This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.
This study looks at how well statins work in older stroke or TIA patients who are already taking them and also have some frailty. The goal is to understand if continuing statins is safe and helpful for this group.
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
This trial tests if adding a statin to beta blocker treatment helps people with advanced liver disease (cirrhosis) who have had complications like fluid buildup, confusion, or bleeding. It is for patients who are already taking a non-selective beta blocker and will be followed for 12 months.
Hear when a new Statin Adverse Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.